# Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction

> **NCT04698343** · NA · COMPLETED · sponsor: **Noctrix Health, Inc.** · enrollment: 21 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DEVICE:** Noninvasive Peripheral Nerve Stimulation (NPNS)

## Key facts

- **NCT ID:** NCT04698343
- **Lead sponsor:** Noctrix Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-06
- **Primary completion:** 2023-02-27
- **Final completion:** 2023-03-28
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04698343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04698343, "Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04698343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*